Costs and Effects of an Ambulatory Geriatric Unit (the AGe-FIT Study): A Randomized Controlled Trial  by Ekdahl, Anne W. et al.
JAMDA 16 (2015) 497e503JAMDA
journal homepage: www.jamda.comOriginal StudyCosts and Effects of an Ambulatory Geriatric Unit
(the AGe-FIT Study): A Randomized Controlled Trial
Anne W. Ekdahl MD, PhD a,b,*, Ann-Britt Wirehn PhD c, Jenny Alwin PhD d,
Tiny Jaarsma RN, PhD e, Mitra Unosson RN, PhD e, Magnus Husberg BA d,
Jeanette Eckerblad RN, MSc e, Anna Milberg MD, PhD e,f, Barbro Krevers OcT, PhD d,
Per Carlsson PhD d
aDepartment of Geriatric Medicine and Department of Social and Welfare Studies, Linköping University, Linköping, Sweden
bDivision of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
c Local Health Care Research and Development Unit, County Council in Östergötland, Linköping University, Linköping, Sweden
dDivision of Health Care Analysis, Department of Medical and Health Sciences, Faculty of Health Sciences, Linkoping University, Linköping, Sweden
eDepartment of Social and Welfare Studies, Linköping University, Norrköping, Sweden
fDepartment of Advanced Home Care and Department of Social and Welfare Studies, Linköping University, Norrköping, SwedenKeywords:
Comprehensive geriatric assessment
ambulatory geriatric care
multimorbidity
randomized controlled trial
security
hospitalization
costsThe authors declare no conﬂicts of interest.
This study was funded by a common public re
Östergötland County Council (grant numbers LIO-124
the Swedish Ministry of Health and Social Affairs (gran
Foundation, and National Society for Research on Age
* Address correspondence to Anne W. Ekdahl, MD,
Medicine, Gamla Ö vägen 25, 601 82 Norrkoping, Sw
E-mail addresses: anne.ekdahl@ki.se, anne.ekdahl@
http://dx.doi.org/10.1016/j.jamda.2015.01.074
1525-8610/ 2015 AMDA e The Society for Post-Acute
org/licenses/by-nc-nd/4.0/).a b s t r a c t
Objectives: To examine costs and effects of care based on comprehensive geriatric assessment (CGA)
provided by an ambulatory geriatric care unit (AGU) in addition to usual care.
Design: Assessor-blinded, single-center randomized controlled trial.
Setting: AGU in an acute hospital in southeastern Sweden.
Participants: Community-dwelling individuals aged 75 years or older who had received inpatient hospital
care 3 or more times in the past 12 months and had 3 or more concomitant medical diagnoses were
eligible for study inclusion and randomized to the intervention group (IG; n ¼ 208) or control group (CG;
n ¼ 174). Mean age (SD) was 82.5 (4.9) years.
Intervention: Participants in the IG received CGA-based care at the AGU in addition to usual care.
Outcome measures: The primary outcome was number of hospitalizations. Secondary outcomes were
days in hospital and nursing home, mortality, cost of public health and social care, participant’ sense of
security in care, and health-related quality of life (HRQoL).
Results: Baseline characteristics did not differ between groups. The number of hospitalizations did not
differ between the IG (2.1) and CG (2.4), but the number of inpatient days was lower in the IG (11.1 vs
15.2; P ¼ .035). The IG showed trends of reduced mortality (hazard ratio 1.51; 95% conﬁdence interval [CI]
0.988e2.310; P ¼ .057) and an increased sense of security in care interaction. No difference in HRQoL was
observed. Costs for the IG and CG were 33,371£ (39,947£) and 30,490£ (31,568£; P ¼ .432).
Conclusions and relevance: This study of CGA-based care was performed in an ambulatory care setting, in
contrast to the greater part of studies of the effects of CGA, which have been conducted in hospital
settings. This study conﬁrms the superiority of this type of care to elderly people in terms of days in
hospital and sense of security in care interaction and that a shift to more accessible care for older people
with multimorbidity is possible without increasing costs. This study can aid the planning of future in-
terventions for older people.
Trial Registration: clinicaltrials.gov identiﬁer: NCT01446757.
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and Long-Term Care Medicine. ThWith the aging of populations worldwide, increasing numbers of
people are living with multiple chronic conditions and frailty.1,2 Over
many years, hospital care and ambulatory specialist care have been
subdivided into numerous entities, based mainly on medical spe-
cialty.3 This division has led care providers to focus on the treatment
of one or a few diseases instead of addressing multimorbidity, which
in turn can lead to polypharmacy and medication errors.4 Olderis is an open access article under the CC BY-NC-ND license (http://creativecommons.
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considers the entire spectrum of their life situations, including the
sense of security in care.7
Comprehensive geriatric assessment (CGA) is a multidimensional,
interdisciplinary diagnostic process used to determine the medical,
psychological, and functional capabilities of frail older people. Evi-
dence suggests that CGA-based care is superior to usual care in terms
of improving functional capacity and reducing the risk of in-
stitutionalization.8e12 Health care providers, however, have been
reluctant to organize this kind of care, probably because of the
anticipation of increased costs and the need for substantial shifts in
practice toward interprofessional teamwork and gerontological and
geriatric competences.
Older people with multimorbidity often require hospital care to
optimize the treatment of chronic diseases or to diagnose and treat
newly arising conditions. At the same time, avoidance of unnecessary
hospitalization is important because of the associated risks of frac-
ture, medication error, patient confusion, and further disability13e16
and the high costs of this type of care. A Cochrane report based on
22 randomized controlled trials (RCTs) found no signiﬁcant difference
in rehospitalization associated with the use of CGA in a hospital care
setting.11 Because of differences among trials in the reporting of costs
and outcome measures, the authors of this report could make no
conclusion concerning resource utilization. These ﬁndings were
replicated in a recent review on the same subject based on 19 RCTs.17
None of these studies reported on the effects of CGA on patients’
quality of life.
Objectives
Most studies of CGA have examined inpatient hospital care; few
have been conducted in ambulatory care settings.18,19 To the authors’
knowledge, no study of CGA has included the outcome measures of
quality of life, sense of security, or total cost of social and health care.
The aim of this study was thus to compare costs and effects between
participants with access to CGA at an ambulatory geriatric unit and a
control group receiving usual care only. This article reports the ﬁrst
results after 24 months of follow-up. The study hypothesis was that
CGA-based care provided in an ambulatory geriatric unit would
reduce hospitalizations (primary outcome) compared with usual care.
Analyses also were conducted to compare the number of inpatient
days, total cost of health and social care, mortality, care in nursing
home, patients’ sense of security in care, and health-related quality of
life (HRQoL).
Methods
Trial Design
The Ambulatory Geriatric Assessmentda Frailty Intervention Trial
(AGe-FIT) was designed as a randomized, controlled, assessor-
blinded, single-center trial with 2 parallel groups. Participants were
randomized to the intervention group, which received interdisci-
plinary care based on CGA at an ambulatory geriatric unit in addition
to usual care, or the control group, which received usual care only.
Outcomes were assessed at baseline and 12 and 24 months later. The
protocol has been described in detail previously.20 The regional
ethical review board in Linköping, Sweden, approved the study (Dnr.
2011/41e31) and all participants provided written informed consent.
Study Setting
Data were collected between February 2011 and December 2013
in a municipality in southeastern Sweden, which contains rural andurban areas and had approximately 130,000 inhabitants, 8.3% of
whom were 75 years or older.21 The county council and municipality
are responsible for the provision of health and social care, funded
mainly by income taxes. Most health care is provided at 10 primary
centers and 1 hospital, which has approximately 300 beds and 12
specialist departments and offers 24-hour admittance for surgical and
medical emergencies. The municipality provides home health and
social care, including care provision in nursing homes (ie, special
accommodations for elderly patients) when needed. Home care
typically includes home help services to support older people in
conducting activities of daily living (ADLs) and instrumental ADLs.
Participants
Potential participants were identiﬁed using the care data ware-
house of Östergötland, a population-based administrative database
maintained by the county council.22 Community-dwelling individuals
75 years or older who had received inpatient hospital care 3 or more
times in the previous 12 months and had 3 or more concomitant
medical diagnoseswere considered eligible to participate in this study.
Randomization and Blinding
Eligible participants were assigned randomly to the intervention
or control group based on a randomization master list using SPSS
software (version 18.0; SPSS Inc., Chicago, IL; Figure 1). Only the
project coordinator and the nurse who planned the schedules of
physicians working in the ambulatory geriatric unit had access to the
randomization protocol.
Procedures
All eligible participants received an invitation letter by post that
included information about the purpose and protocol of the study.
They were then contacted by telephone and asked to provide verbal
informed consent to study participation, and home visits were made
to collect further information and obtain written informed consent.
The group identities were thus blinded to both the assessors and
participants at baseline.
Baseline Assessment and Outcome Measures
For consenting participants at baseline and 12 and 24 months
thereafter, registered nurses and a registered occupational therapist
(ie, assessors) who were not involved in other aspects of participants’
care conducted assessments in participants’ homes.20 They conducted
interviews to collect background data (eg, age, sex, educational level,
cohabitation, hearing and vision problems) and to assess indepen-
dence in ADLs, cognition, sense of security in care, and HRQoL. In-
dependence in ADLs was assessed using the Barthel index,23 which
has shown good reliability and validity.24 Cognition was assessed
using the Mini Mental State Examination,25 which includes measures
of orientation, immediate and short-term memory, attention and
calculation, and language and praxis. This instrument has been found
to have good construct validity.26
Patients’ sense of security in care was measured by the Sense of
Security in CaredPatients’ Evaluation (SEC-P), which has been shown
to have good validity and reliability, including in samples of older
people. The instrument contains 3 scales: care interaction (8 items),
identity (4 items), and mastery (3 items). Responses are structured by
a 6-point Likert scale (1 ¼ never, 6 ¼ always).27
HRQoL was measured using the generic preference-based 3-level
version of the 5-dimensional (mobility, self-care, usual activities,
pain/discomfort, and anxiety/depression) EuroQol instrument
Fig. 1. Flow chart of participant selection and assessment. *Community dwelling, age 75 years, received inpatient hospital care 3 or more times in the past 12 months, 3 or more
concomitant medical diagnoses identiﬁed from a population-based administrative database. yPopulation-based administrative database administered by the County Council.18
zAfter 3 telephone calls, no further attempt was made to reach participants at baseline.
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problem,” “some problems,” and “severe problems.” The EQ-5D
questionnaire has been shown to be a simple, valid and responsive
measure of HRQoL.29e31
Intervention
The ambulatory geriatric unit was opened at the time of study
initiation with a diverse team of professionals: a nurse, a geriatrician/
residentphysician, amunicipal caremanager, anoccupational therapist,
a physiotherapist, a dietician, and an administrative assistant. Access to
other professionals (eg, dental hygienist, psychologist) was readily
available on demand. After baseline assessment by research personnel,
participants in the intervention group were invited to receive individ-
ually tailored care and attend follow-up visits at the ambulatory geri-
atric unit during the studyperiod.20 Initial CGAwasperformedbased on
a standardized procedure.20 Thereafter, all care was personalized ac-
cording to patients’ situations and preferences, best-known evidence
and practice, and team members’ competences. However, nurses clin-
ically reassessed all participants after 1 year and then initialized (home)
visits by physicians or other professionals if needed. Ambulatory geri-
atric unit staff planned participants’ care during team meetings, with
the common goal of increasing participants’ quality of life.During the study period, the team’s social care manager contacted
all participants in the intervention group to inform them of available
formsof support fromthemunicipality, suchashomehelp services. The
intensity of clinical follow-up depended on participants’ needs and
demands, ranging from a few contacts per year to daily or weekly
contacts by telephone or ambulatory or home visits. Intervention ac-
tivities (clinical assessments, home or ambulatory visits, telephone
calls) were most intensive at the beginning of the intervention period.
Many intervention activities had preventive goals (eg, training pro-
grams conducted by a physiotherapist, fall prevention measures per-
formed by a physiotherapist and occupational therapist during home
visits, and optimization of pharmacotherapy with the help of clinical
pharmacists). Nurses also ensured that patients understood new pre-
scriptions and provided advice and counsel by telephone. Team
members from the ambulatoryunit visitedparticipants admitted to the
hospital to provide further information to patients and staff with the
goal of facilitating care, discharge, and/or transfer toother types of care.
Usual Care
Participants allocated to the control group received usual health
and social care (ie, health care provided by primary care centers, in-
and outpatient hospital care, and social care as usual). They did not
Table 1
Baseline Characteristics of the Intervention and Control Groups
Characteristic Intervention Control
No. 208 174
Age, y, mean (SD) 82.3 (4.6) 82.7 (5.1)
Sex, female, n (%) 108 (47) 81 (50)
Living alone, n (%) 102 (49) 93 (54)
Primary school only, n (%) 127 (62) 109 (63)
Hearing impairment with hearing aid, n (%) 75 (36) 59 (34)
Vision impairment with glasses, n (%) 49 (24) 56 (32)
Mini-Mental State Examination score, mean (SD) 26.2 (3.3) 26.6 (3.0)
Barthel index score, mean (SD) 89.6 (14.8) 92.0.(9.9)
Previous diagnoses,*n (%)
Certain infectious and parasitic
diseases (A00eB99)
97 (47) 71 (41)
Neoplasms (C00eD48) 89 (43) 70 (40)
Diseases of the blood and blood-forming
organs and certain disorders involving the
immune mechanism (D50eD89)
60 (30) 56 (32)
Endocrine, nutritional, and
metabolic diseases (E00eE90)
102 (49) 87 (50)
Mental and behavioral disorders (F00eF99) 78 (38) 53 (31)
Diseases of the nervous system (G00eG99) 78 (38) 53 (30)
Diseases of the circulatory system (I00eI99) 197 (95) 169 (97)
Diseases of the respiratory system (J00eJ99) 112 (54) 100 (56)
Diseases of the digestive system (K00eK93) 117 (56) 91 (52)
Diseases of the musculoskeletal system/
connective tissue (M00eM99)
167 (80) 132 (76)
Symptoms, signs, and abnormal clinical/
laboratory ﬁndings, not elsewhere classiﬁed
207 (100) 174 (99)
*Codes are taken from the International Classiﬁcation of Diseases, 10th edition.
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intervention group had the same access to usual care.
Primary and Secondary Outcomes
The primary outcome assessed was hospitalization during the 24-
month study period. Secondary outcomes were the number of days in
hospital, mortality, admittance to a nursing home, total cost of health
and social care, and participants’ sense of security in care and HRQoL.
Dates of death were collected from electronic medical records
linked to the MASTER Swedish total population register.32 Costs of
health care consumption, including inpatient care, ambulatory visits,
and prescribed drugs, were obtained from the care data warehouse of
Östergötland and the cost per patient and prescribed drug databases.
The Östergötland data warehouse contains administrative informa-
tion about patients’ characteristics, visits to health care providers, and
hospitalizations (including number of inpatient days), with registry of
primary and secondary diagnoses for each contact. Data were ex-
tracted from the Östergötland data warehouse in June 2014. The cost
per patient database is linked to this data warehouse and records
costs for each contact. The county council’s prescribed drug database
contains local information extracted from national pharmaceutical
data on the volumes and costs of prescribed and dispensed drugs.
Information on participants’ use hours of home help services, transfer
to nursing homes, and days spent at nursing homes was obtained
from the social care managers’ records.
Sample Size
Sample size calculation was based on a 2-tailed signiﬁcance level
of 5%, power of 80%, and an expected detectable effect over
24 months of a 20% reduction in the mean hospital admission rate
from 5 to 4 admissions per year, leading to a minimum requirement
of 142 participants per trial arm. Based on previous research con-
ducted in the area, we anticipated approximately 40% attrition over
the 24-month study period for reasons such as death, withdrawal
from the study, and relocation.33e35 The estimated sample size was
thus increased by 40%; we aimed to include 200 participants in each
group to enable detection of a signiﬁcant difference in hospitaliza-
tions over the 24-month period.20
Statistical Analyses
Student’s t test was used to compare continuous data between the
intervention and control groups, and the c2 test was used to compare
categorical data. Mean costs of health and social care were calculated
for the 2 groups, and mean differences (D) between groups were
determined after 24 months. All cost estimates are presented in 2013
British Pounds (GBP). All recruited participants (intention-to-treat
sample) were included in mortality and cost of care analyses, and
patients following the protocol (ie, those who received care at the
ambulatory geriatric unit) were included in an additional mortality
analysis.
Mortality rates after 24 months were calculated as percentages of
deaths in the total population per group. A Cox proportional-hazard
regression model in which the number of months from the time of
study inclusion until death served as the follow-up time variable was
used to calculate hazard ratios (HRs) for death with 95% conﬁdence
intervals (CIs). The number of months to mortality is also presented
using a Kaplan-Meier curve.
To assess participants’ sense of security in care, mean SEC-P scale
scores were compared between groups. HRQoL was examined using a
primary analysis based on participants’ responses at all 3 assessment
time points and 3 sensitivity analyses that included patients forwhom EQ-5D-3 L scores from 1 or more time points were missing.36
In the ﬁrst sensitivity analysis, missing values were preferably
replaced with participants’ last available EQ-5D-3 L score (carry
forward); when no preceding value was available, the following
available value was used (carry backward). In the second sensitivity
analysis, a value of 0 was assigned for deceased persons to assess-
ment time points following dates of death. The third sensitivity
analysis combined the methods used in the ﬁrst 2 sensitivity
analyses. In all statistical tests, the signiﬁcance level was set to P less
than .05.Results
Participants and Baseline Characteristics
Between January and November 2011, 844 eligible patients were
randomized to the intervention and control groups. Of these, 382
(45%) individuals consented to participation and were enrolled in the
study (mean age, 82.5 years; 48% female). A total of 130 participants
were lost during the study period; 87 (23%) of these individuals died
(Figure 1). No baseline characteristic differed signiﬁcantly between
groups (Table 1). Participants in both groups were severely affected
by diseases, and frequencies of hearing and vision problems and
cognitive decline were high. More than 90% of participants had pre-
viously been diagnosed with cardiovascular diseases.Outcomes
Hospitalization
The mean number of hospitalizations per patient did not differ
signiﬁcantly between groups (intervention, 2.1 [SD 2.6]; control, 2.4
[2.5]; P ¼ .212). The mean number of inpatient days during the 24-
month follow-up period was smaller in the intervention group (11.1
[15.9]) than in the control group (15.2 [20.2]; P ¼ .035).
Fig. 2. Kaplan-Meier mortality curves from the time of study inclusion. Intention-
to-treat sample, HR 1.51, 95% CI 0.99e2.31, P ¼ .057.
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The total cost of health and social care did not differ between
groups during the 24-month period after baseline assessment (GBP/
patient [SD]: intervention, 33,371 [39,947]; control, 30,490 [31,568];
P ¼ .432). Costs of primary care and in- and outpatient hospital care
are presented in Table 2. The intervention resulted in higher costs for
ambulatory care, such as for visits to physicians and other staff and
operative activities (eg, telephone calls placed by ambulatory unit
staff), but lower costs for inpatient hospital care. Participants in the
intervention group used 25% more hours of home help services (373
vs 298 hours) during the study period and spent 20% fewer days in
nursing homes (29 vs 36 days) than did those in the control group,
but these differences were not signiﬁcant.
Mortality
Mortality rates 24 months after study enrolment were 18.8%
(n ¼ 39) in the intervention group and 27.0% (n ¼ 47) in the control
group (HR 1.51, 95% CI 0.99e2.31, P ¼ .057). For the Kaplan-Meyer
survival curve, see Figure 2. Participants in the intervention group
lived an average of 30.9 days longer than did those in the control
group. Per-protocol analysis (excluding 11 participants who never
took part in the intervention after baseline assessment) showed that
mortality was lower in the intervention group than in the control
group (HR 1.60, 95% CI 1.04e2.49, P ¼ .035).
Nursing home admittance
Twenty-six (12.5%) participants in the intervention group and 33
(18.9%) in the control group were moved to nursing homes (HR 1.63,
95% CI 0.969e2.421, P ¼ .065).
Participants’ sense of security in care
SEC-P scale scores did not differ signiﬁcantly between groups at
baseline. Care interaction scores were higher in the intervention group
than in the control group at 12 (P ¼ .005) and 24 months (P < .001),
but identity and mastery scores did not differ signiﬁcantly (Table 3).
HRQoL
Baseline EQ-5D-3 L scores were 0.62 in the intervention group and
0.63 in the control group. The primary analysis, including allTable 2
Costs of Primary Care and Inpatient and Outpatient Hospital Care During the 24-Month
Primary Health
Care
Hospital Care
Ambulatory
Geriatric Care
Othe
Amb
Care
IG CG IG CG IG
Visits to physicians 200 399 1252 NA 1118
Visits to other staffy 1307 1272 965 NA 383
Incidental/operative costsz 222 230 873 NA 123
Hospital-based home health care NA NA NA NA 322
In-hospital care NA NA NA NA NA
Operative and ICU care 32 47 NA NA 134
Laboratory and other investigations 84 184 234 NA 545
Pharmaceuticals 436 879 362 NA 522
Helping aids 166 218 NA NA 71
Other 227 253 393 NA 442
Home help servicesx
Institutional livingk
Total 2674 3482 4079 NA 3660
Mean values (in GBP) are presented without SDs for readability, but SDs were used to ca
CG, control group (n ¼ 174); ICU, intensive care unit; IG, intervention group (n ¼ 208);
x£30/h and k£ 166/d according to the administration of the municipality of Norrköping.
*CGeIG.
yNurse, occupational therapist, physiotherapist, or other health care personnel.
zTelephone calls, administration, education, premises, and so forth.participants and the 3 sensitivity analyses showed no signiﬁcant
difference in HRQoL between groups at baseline or after 12 or
24 months (Table 4).Discussion
Although the CGA-based intervention involved the provision of
comprehensive care and active follow-up by a multidisciplinary
professional team, it was not signiﬁcantly more expensive than usual
care. The cost of ambulatory care was higher as a result of the
increased level of services offered by the ambulatory geriatric unit,
but the cost of inpatient hospital care was lower. Although thePeriod after Baseline Assessment
Total
r
ulatory
In Hospital
Inpatient Care
CG IG CG IG CG D* P
1180 NA NA 2570 1579 991 <.001
620 NA NA 2655 1892 763 .024
119 NA NA 1218 349 869 <.001
140 NA NA 322 140 182 .118
NA 3982 5456 3982 5456 1474 .043
114 1054 1016 1220 1177 43 .900
577 809 891 1672 1652 20 .933
407 624 470 1944 1756 188 .539
85 1 1 238 304 66 .279
441 473 576 1535 1270 265 .082
11,229 8963 2266 .361
4784 5952 1168 .509
3683 6943 8410 33,371 30,490 2881 .432
lculate P values.
NA, not applicable.
Table 3
Participants’ Sense of Security in Care at Baseline and 12 and 24 Months
Sense of Security Scale Intervention
(n ¼ 208)
Control (n ¼ 175) P*
n Mean SD n Mean SD
Care interaction scale
Baseline 194 4.67 1.05 164 4.82 0.99 .152
12 mo 157 5.18 0.89 117 4.84 1.03 .005
24 mo 138 5.27 0.82 98 4.70 1.11 <.001
Mastery scale
Baseline 205 4.67 1.19 171 4.80 1.10 .291
12 mo 164 4.85 1.06 121 4.84 1.09 .935
24 mo 141 5.06 0.94 99 4.96 0.95 .457
Identity scale
Baseline 203 5.32 0.69 169 5.33 0.72 .873
12 mo 161 5.33 0.74 117 5.38 0.72 .597
24 mo 143 5.30 0.75 97 5.21 0.82 .361
*Two-tailed.
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to the emergency room or directly to a ward, participants in the
intervention group spent fewer days in hospital and tended to spend
fewer days in nursing homes than did those in the control group. The
intervention resulted in a nonsigniﬁcant but potentially clinically
relevant decrease in mortality; this reduction was signiﬁcant in the
per-protocol analysis. It had no observable effect on HRQoL, but
improved participants’ sense of security in care interaction.
This study has several strengths. As the intervention was exam-
ined in a real-world municipal setting, the results are likely gener-
alizable to other settings. As no additional training was provided to
primary care centers, data were collected in a setting similar to that in
most communities with wide variation in the quantity and quality of
care provided to older people. Strength is the examined outcomes in
multiple dimensions, including HRQoL, total costs of health and social
care, sense of security, and that the research of team-based care in an
ambulatory setting is scarce.
The 24-month follow-up period constitutes a limitation of the
present study. The CGA intervention may have had a larger effect
with a longer follow-up period, as much of the care provided at the
ambulatory geriatric unit was preventive. Examples of such care areTable 4
Weighted Analysis of HRQoL at Baseline and 12 and 24 Months
Intervention,
n ¼ 208
Control,
n ¼ 175
P
n Mean  SD n Mean  SD
Primary analysis, full EQ-5D-3 L questionnaire population
Inclusion 183 0.62  0.31 147 0.63  0.28 .780
12-mo follow-up 167 0.62  0.33 124 0.64  0.30 .569
24-mo follow-up 144 0.60  0.30 103 0.62  0.30 .554
1st sensitivity analysis, missing data replacement by carrying forward/
backward
Inclusion 199 0.62  0.31 163 0.63  0.29 .737
12-mo follow-up 182 0.61  0.33 147 0.63  0.30 .624
24-mo follow-up 168 0.59  0.31 126 0.62  0.29 .278
2nd sensitivity analysis, deceased patients given HRQoL value of 0 after time of
death
Inclusion 183 0.62  0.31 147 0.63  0.28 .780
12-mo follow-up 191 0.54  0.37 147 0.54  0.36 .977
24-mo follow-up 183 0.47  0.36 150 0.43  0.38 .278
3rd sensitivity analysis, missing data replacement by carrying forward/
backward and deceased patients given HRQoL value of 0 after time of death
Inclusion 199 0.62  0.31 163 0.63  0.29 .737
12-mo follow-up 206 0.54  0.36 170 0.54  0.35 .930
24-mo follow-up 207 0.47  0.36 173 0.45  0.37 .591
HRQoL, health-related quality of life.the optimization of medications, minimization of fall risks, rehabili-
tation, initialization of osteoporosis treatment, attendance at meals to
provide social support, and securing of participants’ ability to take
walks outdoors if they so desired.20 The effects of such interventions
in older people with multimorbidities likely manifest over a period
longer than 24 months. We were not able to detect a signiﬁcant
reduction in total number of hospitalizations, which could be ex-
plained by an underpowered study regarding this outcome, but also
that this measure may not be valid, as patients can be moved be-
tween wards and clinics several times within the same hospitaliza-
tion period, with each move recorded as a new hospitalization event.
The number of days in hospital would likely be a better primary
outcome than the number of hospitalizations, as we believe that it is
a better measure of the need for hospital care.
The different sizes in the groups could be explained by a limited
availability of physicians at the end of the inclusion period. The
participants in the intervention group were therefore asked earlier in
the inclusion period if they wanted to participate than the partici-
pants in the control group. Because of an unexpected high refusal rate
in December (which we should have been able to foresee because of
Christmas time) we never managed to reach the desired number in
the control group during the planned time for inclusion. Because of
limited ﬁnancial resources, we were not able to prolong the inclusion
period beyond 2011.
The results of this study conﬁrm previous ﬁndings regarding the
provision of team-based care in a hospital setting: not more expen-
sive due to shorter or similar length of stay in hospital.37,38 We found
3 reviews with preventive home visiting to frail older people39e41 as
the intervention. In our study, home visiting was a part of the
intervention, but phone calls and visits to the ambulatory were more
often used. The reviews have shown diverging results with regard to
reduction in mortality, reduction in admission to long-term institu-
tional care, and reduction in admission to hospital, and the conclu-
sions have been very cautious as to why it seems more
comprehensive care is needed to give positive effects.
We have found only a few studies of the effects and outcomes of
team-based care in an ambulatory setting as in ours. An early report
by Tulloch and Moore19 showed that more health and social services
were provided to the intervention group due to the identiﬁcation of
medical or social conditions that would otherwise remain untreated,
as in our study. Similarly, Weinberger et al42 determined that active
follow-up after hospitalization increased rather than decreased the
rate of rehospitalization, due to the identiﬁcation of previously un-
detected health problems in an older population with heart failure.
The ﬁndings regarding health and social care costs with no sig-
niﬁcant differences are in agreement with those of a very similar RCT
published in 2001.18 The lack of an effect on HRQoL is also in agree-
ment with previous studies.40,42 This result may reﬂect participants’
poor health status and thus low overall HRQoL, and the limited ability
to improve these aspects of health.
This study demonstrated that a shift from inpatient hospital or
nursing home care to more preventive and accessible ambulatory
care provision to older people with multimorbidity is possible
without increasing costs. Thus, systematic assessment and the pro-
vision of personalized interdisciplinary care may be a promising
means to improve outcomes. The similarity in cost may be explained
by the identiﬁcation of unmet needs, which led to more health care
contacts (eg, to ensure compliance with medications and the receipt
of adequate home help services). The reduced duration of hospitali-
zation may be explained by the admission of patients in earlier dis-
ease stages and/or less serious conditions due to active follow-up.
This type of support may have contributed to intervention group
participants’ increased sense of security in their interactions with
care.43
A.W. Ekdahl et al. / JAMDA 16 (2015) 497e503 503These ﬁndings provide new insight on the effectiveness of
ambulatory geriatric units and can aid the planning of future in-
terventions for older people. The increased sense of security in care
among intervention participants in the present study generates the
political question of the monetary value of this improvement. To our
knowledge, this study is the ﬁrst to contribute scientiﬁc knowledge
about these important aspects. The intervention should be studied
further in multicenter studies with longer follow-up periods to
evaluate the preventive actions taken by the ambulatory geriatric
unit.
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